#indianipo

[newipoinfo12]

Sudeep Pharma IPO Date Price, Allotment Details

November 25, 2025. The Sudip Pharma IPO is a book-build issue. The company will raise approximately ₹895 crore through the IPO, consisting of a fresh issue of shares worth ₹95.00 crore and an offer for sale of 1,34,90,726 equity shares with a face value of ₹1.

The price band for the Sudip Pharma IPO is ₹563 to ₹593 per share. The retail share is 35%, QIBs 50%, and HNIs 15%. The Sudip Pharma IPO will be listed on the BSE and NSE on November 28, 2025. The allotment for the Sudip Pharma IPO will take place on November 26, 2025. hashtags for

[colitcomediasblog]

Findi Limited Gears Up for Indian IPO with DAM Capital and Ambit as Lead Advisors

In a major strategic development, Findi Limited, a prominent financial infrastructure and inclusion company, has announced its move to go public in India. The company has appointed DAM Capital Advisors Ltd and Ambit Pvt Ltd as the lead managers for its upcoming Indian IPO, paving the way for a significant milestone in its corporate journey.

With a mission to revolutionize access to financial services in India, this IPO plan not only aims to raise capital but also solidifies Findi's growing presence in one of the world’s fastest-growing economies. Findi Limited has consistently played a pivotal role in bridging the financial divide, especially in semi-urban and rural areas where access to basic banking services remains a challenge. With its robust infrastructure and strong merchant network, Findi provides seamless, secure, and efficient digital transactions to millions of Indians.

By tapping into the Indian stock market, Findi aims to scale up operations and deliver financial solutions to even more underserved communities, reinforcing its commitment to inclusive growth.

[colitco]

🚀 Findi Appoints DAM Capital and Ambit as Lead Managers for Indian IPO of TSI Subsidiary 🇮🇳💳

Findi Limited (ASX: FND) has taken a major step towards the planned IPO of its Indian subsidiary, Transaction Solutions International (India) Pvt Ltd (TSI), appointing DAM Capital Advisors as Left Lead Banker and Ambit Private Limited as Book Running Lead Managers.

💡 “The selection of DAM Capital and Ambit marks a key milestone in unlocking value for Findi shareholders,” said Findi Executive Chairman Nicholas Smedley.

The IPO is targeted for completion by the end of 2026, providing Findi with a platform to further scale its payments and ATM business in one of the world’s largest digital economies.

With India’s booming fintech sector and listed peers including Paytm, Mobikwik, and CMS Info Systems, TSI’s IPO positions Findi to enhance shareholder value and market presence.

Current Share Price: $4.33 AUD

Market Outlook: India’s transaction banking, ATM and digital payments sector continues to see robust growth, making this IPO strategically timed.

🔗 Full Announcement - https://colitco.com/findi-appoints-dam-capital-ambit-lead-tsis-indian-ipo/

Also Visit - https://crafmin.com/findi-appoints-dam-capital-ambit-lead-tsis-indian-ipo/